|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 07/05/14 | Actavis : Factbox - M&A frenzy transforming global pharma | RE |
| 06/05/14 | Actavis : M&A frenzy in healthcare sector | RE |
Company details: Forest Laboratories, Inc.
Forest Laboratories, Inc.
909 Third Avenue
10022-4731, New York
+212-421-7850
Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.49% | -1.91% | +56.36% | +106.68% | 1,034B | |
| +1.01% | +4.56% | +56.12% | +72.95% | 663B | |
| -0.39% | +0.94% | +23.00% | +78.36% | 462B | |
| +2.09% | -2.06% | +32.28% | +38.37% | 344B | |
| 0.00% | +5.36% | +27.40% | +47.50% | 307B | |
| +1.42% | +0.26% | -0.52% | +13.62% | 251B | |
| +0.21% | +1.43% | +56.15% | +74.49% | 239B | |
| -0.03% | +2.13% | -17.30% | -53.99% | 207B | |
| +0.42% | +0.97% | +33.03% | +99.99% | 186B | |
| Average | +0.65% | -0.70% | +29.61% | +53.11% | 410.37B | |
| Weighted average by Cap. | +0.47% | -0.84% | +38.31% | +68.05% |
- Stock Market
- Stocks
- Stock
- Company Forest Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
